prikaz prve stranice dokumenta An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations
Access restricted to all Croatian higher education institution's students and staff
Scientific paper - Review paper
An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations
The Lancet Global Health, 11 (2023), 3; e466-e474. https://doi.org/10.1016/S2214-109X(23)00019-0
Charani, Esmita; Mendelson, Marc; Pallett, Scott J C; Ahmad, Raheelah; Mpundu, Mirfin; Mbamalu, Oluchi; Bonaconsa, Candice; Nampoothiri, Vrinda; Singh, Sanjeev; Peiffer-Smadja, Nathan; Anton-Vazquez, Vanesa; Moore, Luke S P; Schouten, Jeroen; Kostyanev, Tomislav; Vlahović-Palčevski, Vera; Kofteridis, Diamantis; Corrêa, Juliana Silva; Holmes, Alison H More authors...

Cite this document

Charani, E., Mendelson, M., Pallett, S. J. C., Ahmad, R., Mpundu, M., Mbamalu, O. ... Holmes, A. H. (2023). An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations. The Lancet Global Health, 11. (3), e466-e474. doi: 10.1016/S2214-109X(23)00019-0

Charani, Esmita, et al. "An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations." The Lancet Global Health, vol. 11, no. 3, 2023, pp. e466-e474. https://doi.org/10.1016/S2214-109X(23)00019-0

Charani, Esmita, Marc Mendelson, Scott J C Pallett, Raheelah Ahmad, Mirfin Mpundu, Oluchi Mbamalu, Candice Bonaconsa, et al. "An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations." The Lancet Global Health 11, no. 3 (2023): e466-e474. https://doi.org/10.1016/S2214-109X(23)00019-0

Charani, E., et al. (2023) 'An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations', The Lancet Global Health, 11(3), pp. e466-e474. doi: 10.1016/S2214-109X(23)00019-0

Charani E, Mendelson M, Pallett SJC, Ahmad R, Mpundu M, Mbamalu O, and sur.. An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations. The Lancet Global Health [Internet]. 2023 March [cited 2025 January 23];11(3):e466-e474. doi: 10.1016/S2214-109X(23)00019-0

E. Charani, et al., "An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations", The Lancet Global Health, vol. 11, no. 3, pp. e466-e474, March 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:394341. [Accessed: 23 January 2025]

Please login to the repository to save this object to your list.
Metadata
Title (english)An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations
AuthorEsmita Charani
AuthorMarc Mendelson
AuthorScott J C Pallett
AuthorRaheelah Ahmad
AuthorMirfin Mpundu
AuthorOluchi Mbamalu
AuthorCandice Bonaconsa
AuthorVrinda Nampoothiri
AuthorSanjeev Singh
AuthorNathan Peiffer-Smadja
AuthorVanesa Anton-Vazquez
AuthorLuke S P Moore
AuthorJeroen Schouten
AuthorTomislav Kostyanev
AuthorVera Vlahović-Palčevski
AuthorDiamantis Kofteridis
AuthorJuliana Silva Corrêa
AuthorAlison H Holmes
Author's institutionUniversity of Rijeka
Faculty of Health Studies
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Clinical Pharmacology and Toxicology
Abstract (english)
At the 2015 World Health Assembly, UN member states adopted a resolution that committed to the development of national action plans (NAPs) for antimicrobial resistance (AMR). The political determination to commit to NAPs and the availability of robust governance structures to assure sustainable translation of the identified NAP objectives from policy to practice remain major barriers to progress. Inter-country variability in economic and political resilience and resource constraints could be fundamental barriers to progressing AMR NAPs. Although there have been regional and global analyses of NAPs from a One Health and policy perspective, a global assessment of the NAP objectives targeting antimicrobial use in human populations is needed. In this Health Policy, we report a systematic evidence synthesis of existing NAPs that are aimed at tackling AMR in human populations. We find marked gaps and variability in maturity of NAP development and operationalisation across the domains of: (1) policy and strategic planning; (2) medicines management and prescribing systems; (3) technology for optimised antimicrobial prescribing; (4) context, culture, and behaviours; (5) operational delivery and monitoring; and (6) patient and public engagement and involvement. The gaps identified in these domains highlight opportunities to facilitate sustainable delivery and operationalisation of NAPs. The findings from this analysis can be used at country, regional, and global levels to identify AMR-related priorities that are relevant to infrastructure needs and contexts.
Languageenglish
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleThe Lancet Global Health
Numberingvol. 11, no. 3, pp. e466-e474
p-ISSN2214-109X
DOIhttps://doi.org/10.1016/S2214-109X(23)00019-0
URN:NBNurn:nbn:hr:184:394341
Publication2023-03
Document URLhttps://linkinghub.elsevier.com/retrieve/pii/S2214109X23000190
Type of resourceText
Access conditionsRestricted access
Terms of useLicence In copyright icon
Created on2024-02-26 13:14:33